Is Thymalin with epitalon legal in the United Kingdom?

The rare combination in this batch that was actually studied as a combination: 266 elderly people followed for six to eight years on thymalin and epithalamin, where the group given both had a 2.5-fold lower mortality rate than controls and a subgroup treated annually for six years had a 4.1-fold reduction. The trial was unblinded, single-centre, from one research group, has never been replicated, and the pineal component in it was a gland extract rather than the synthetic tetrapeptide sold today.

This page has to do something unusual: report an extraordinary claim from a real combination study and then say precisely why it is not settled. The study.

Mechanism: Thymalin is a peptide complex extracted from calf thymus and is claimed to restore thymic-dependent immune function. Epithalamin is a pineal peptide extract; epitalon is the synthetic tetrapeptide derived from that programme and is claimed to act on pineal function, melatonin rhythm and telomerase.

Regulatory history: Neither is approved in the United States. Both are produced and used in Russia within the peptide bioregulator programme, and are sold elsewhere as research chemicals.

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Thymalin with epitalon at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.